BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lei DK, Ollech JE, Andersen M, Weisshof R, Zmeter N, Sossenheimer P, Rubin DT. Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence. Am J Gastroenterol 2019;114:1904-8. [PMID: 31714359 DOI: 10.14309/ajg.0000000000000460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao L, Tian W, Qu W, Li T, Zhu J, Ma H, Cai S. Protease Hydrolysates Ameliorates Inflammation and Intestinal Flora Imbalance in DSS-Induced Colitis Mice. Journal of Food Quality 2021;2021:1-11. [DOI: 10.1155/2021/5536148] [Reference Citation Analysis]
2 Yang Z, Huang Q, Qin J, Zhang X, Jian Y, Lv H, Liu Q, Li M. Molecular Epidemiology and Risk Factors of Clostridium difficile ST81 Infection in a Teaching Hospital in Eastern China. Front Cell Infect Microbiol 2020;10:578098. [PMID: 33425775 DOI: 10.3389/fcimb.2020.578098] [Reference Citation Analysis]
3 Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol 2021;116:1124-47. [PMID: 34003176 DOI: 10.14309/ajg.0000000000001278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dalal RS, Allegretti JR. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease. Curr Opin Gastroenterol 2021;37:336-43. [PMID: 33654015 DOI: 10.1097/MOG.0000000000000739] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sehgal K, Yadav D, Khanna S. The interplay of Clostridioides difficile infection and inflammatory bowel disease. Therap Adv Gastroenterol 2021;14:17562848211020285. [PMID: 34104215 DOI: 10.1177/17562848211020285] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Khanna S. Management of Clostridioides difficile infection in patients with inflammatory bowel disease. Intest Res 2021;19:265-74. [PMID: 32806873 DOI: 10.5217/ir.2020.00045] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Conrad MA, Kelsen JR. Editorial to Temporal Gut Microbial Changes Predict Recurrent Clostridium difficile Infection in Patients With and Without Ulcerative Colitis. Inflamm Bowel Dis 2020;26:1759-60. [PMID: 31968096 DOI: 10.1093/ibd/izz336] [Reference Citation Analysis]
8 Harris HC, Best EL, Normington C, Saint-Lu N, Sablier-Gallis F, de Gunzburg J, Andremont A, Wilcox MH, Chilton CH. Optimization of an Assay To Determine Colonization Resistance to Clostridioides difficile in Fecal Samples from Healthy Subjects and Those Treated with Antibiotics. Antimicrob Agents Chemother 2020;65:e01401-20. [PMID: 33139292 DOI: 10.1128/AAC.01401-20] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kurnik-Łucka M, Pasieka P, Łączak P, Wojnarski M, Jurczyk M, Gil K. Gastrointestinal Dopamine in Inflammatory Bowel Diseases: A Systematic Review. Int J Mol Sci 2021;22:12932. [PMID: 34884737 DOI: 10.3390/ijms222312932] [Reference Citation Analysis]
10 Conley TE, Fiske J, Subramanian S. How to manage: acute severe colitis. Frontline Gastroenterol 2022;13:64-72. [PMID: 34970430 DOI: 10.1136/flgastro-2020-101710] [Reference Citation Analysis]